triamterene has been researched along with Heart Defects, Congenital in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amitai, Y | 1 |
| Leventhal, A | 1 |
| Donaldson, EK | 1 |
| Patrick, J | 1 |
| Sivapragasm, S | 1 |
| Ming, MO | 1 |
| Alleyne, GA | 1 |
2 other studies available for triamterene and Heart Defects, Congenital
| Article | Year |
|---|---|
Folic acid antagonists during pregnancy and risk of birth defects.
Topics: Abnormalities, Drug-Induced; Cleft Lip; Female; Folic Acid Antagonists; Heart Defects, Congenital; H | 2001 |
Effect of triamterene on leucocyte sodium and potassium levels in heart disease.
Topics: Digoxin; Diuretics; Heart Defects, Congenital; Heart Valve Diseases; Humans; Leukocytes; Potassium; | 1976 |